INTS
Intensity Therapeutics, Inc.
Price Chart
Latest Quote
$4.05
-0.03 (-0.74%)
Current Price
| Previous Close | $4.08 |
| Open | $4.10 |
| Day High | $4.12 |
| Day Low | $4.01 |
| Volume | 60,941 |
Stock Information
| Shares Outstanding | 2.70M |
| Total Debt | $102K |
| Cash Equivalents | $10.24M |
| Net Income | $-10.69M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $10.95M |
| EPS (TTM) | $-4.01 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $885K |
| Income | $-10.69M |
| Book/sh | $3.93 |
| Cash/sh | $3.79 |
| Employees | 5 |
Financial Ratios
| Quick Ratio | 4.57 |
| Current Ratio | 4.86 |
| Debt/Eq | 1.02 |
Returns & Margins
| ROA | -90.39% |
| ROE | -207.37% |
Ownership
| Insider Ownership | 4.55% |
| Institutional Ownership | 6.19% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -1.50 |
| P/B | 1.03 |
Analyst Data
| Recommendation | none |
| Target Price | $24.80 |
Technical Indicators
| SMA20 | $3.95 |
| SMA50 | $4.59 |
| SMA200 | $7.62 |
| RSI | 52.07 |
| ATR | 0.2522 |
| Shares Float | 2.48M |
| Short Float | 2.92% |
| Short Ratio | 2.71 |
| Volatility | 3.06 |
| Rel Volume | 1.33 |
Performance History
| Week | +10.20% |
| Month | -13.46% |
| Quarter | -36.52% |
| 6 Months | -61.15% |
| YTD | -60.20% |
| Year | -46.00% |
| 10 Years | -97.28% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $4.05 | 60,941 |
| 2026-06-24 | $4.08 | 152,600 |
| 2026-06-23 | $4.00 | 73,000 |
| 2026-06-22 | $3.93 | 98,400 |
| 2026-06-18 | $3.92 | 43,900 |
| 2026-06-17 | $3.67 | 4,100 |
| 2026-06-16 | $3.71 | 28,100 |
| 2026-06-15 | $3.93 | 47,100 |
| 2026-06-12 | $3.62 | 26,000 |
| 2026-06-11 | $3.67 | 24,900 |
| 2026-06-10 | $3.74 | 14,000 |
| 2026-06-09 | $3.71 | 40,200 |
| 2026-06-08 | $3.78 | 23,500 |
| 2026-06-05 | $3.77 | 19,500 |
| 2026-06-04 | $3.99 | 37,700 |
| 2026-06-03 | $4.02 | 37,400 |
| 2026-06-02 | $4.28 | 26,900 |
| 2026-06-01 | $4.39 | 82,800 |
| 2026-05-29 | $4.39 | 39,500 |
| 2026-05-28 | $4.42 | 33,700 |
| 2026-05-27 | $4.46 | 18,700 |
| 2026-05-26 | $4.68 | 19,400 |
About Intensity Therapeutics, Inc.
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer relapse and metastasis in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.
đ° Latest News
Intensity Therapeutics Inc. (INTS) Upgraded to Buy: Here's Why
Zacks âĸ 2026-05-27T16:00:03Z
Intensity Therapeutics Inc. (INTS) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Zacks âĸ 2026-05-01T13:55:02Z
Intensity Therapeutics Inc. (INTS) Upgraded to Buy: Here's What You Should Know
Zacks âĸ 2026-04-16T16:00:07Z
All You Need to Know About Intensity Therapeutics Inc. (INTS) Rating Upgrade to Buy
Zacks âĸ 2025-12-15T17:00:04Z
BC-Most Active Stocks
Associated Press Finance âĸ 2025-10-31T14:30:18ZIntensity Therapeutics stock up nearly 400% on solid tumour data
Clinical Trials Arena âĸ 2025-10-31T12:19:19Z
Trending tickers: Apple, Amazon, Netflix, Reddit and Intensity Therapeutics
Yahoo Finance UK âĸ 2025-10-31T09:28:20Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $11,972,000 | $16,585,000 | $8,319,000 | $7,550,000 |
| Other Income Expense | $186,000 | $3,000 | $-2,238,000 | $48,000 |
| Other Non Operating Income Expenses | $186,000 | $3,000 | $24,000 | $48,000 |
| Net Non Operating Interest Income Expense | $180,000 | $314,000 | $19,000 | $-80,000 |
| Operating Expense | $11,972,000 | $16,585,000 | $8,319,000 | $7,550,000 |
| General And Administrative Expense | $5,187,000 | $6,089,000 | $3,533,000 | $2,418,000 |
| Interest Expense | - | $0 | $305,000 | $82,000 |
| Interest Expense Non Operating | - | $0 | $305,000 | $82,000 |
| Rent Expense Supplemental | - | - | - | $142,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-11,606,000 | $-16,268,000 | $-10,538,000 | $-7,582,000 |
| Net Interest Income | $180,000 | $314,000 | $19,000 | $-80,000 |
| Interest Income | $180,000 | $314,000 | $324,000 | $2,000 |
| Normalized Income | $-11,606,000 | $-16,268,000 | $-8,276,000 | $-7,582,000 |
| Net Income From Continuing And Discontinued Operation | $-11,606,000 | $-16,268,000 | $-10,538,000 | $-7,582,000 |
| Total Operating Income As Reported | $-11,972,000 | $-16,585,000 | $-8,319,000 | $-7,550,000 |
| Net Income Common Stockholders | $-11,606,000 | $-16,268,000 | $-11,862,000 | $-7,582,000 |
| Net Income | $-11,606,000 | $-16,268,000 | $-10,538,000 | $-7,582,000 |
| Net Income Including Noncontrolling Interests | $-11,606,000 | $-16,268,000 | $-10,538,000 | $-7,582,000 |
| Net Income Continuous Operations | $-11,606,000 | $-16,268,000 | $-10,538,000 | $-7,582,000 |
| Pretax Income | $-11,606,000 | $-16,268,000 | $-10,538,000 | $-7,582,000 |
| Interest Income Non Operating | $180,000 | $314,000 | $324,000 | $2,000 |
| Operating Income | $-11,972,000 | $-16,585,000 | $-8,319,000 | $-7,550,000 |
| Special Income Charges | - | $0 | $-2,262,000 | $0 |
| Per Share | ||||
| Diluted EPS | $-8.56 | $-29.24 | $-34.50 | $-54.73 |
| Basic EPS | $-8.56 | $-29.24 | $-34.50 | $-54.73 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-11,972,000 | $-16,585,000 | $-7,971,000 | $-7,500,000 |
| EBITDA (Bullshit earnings) | $-11,972,000 | $-16,585,000 | $-10,233,000 | $-7,500,000 |
| EBIT | $-11,972,000 | $-16,585,000 | $-10,233,000 | $-7,500,000 |
| Diluted Average Shares | $1,356,358 | $556,279 | $344,652 | $523,975 |
| Basic Average Shares | $1,356,358 | $556,279 | $344,652 | $138,545 |
| Diluted NI Availto Com Stockholders | $-11,606,000 | $-16,268,000 | $-11,862,000 | $-7,582,000 |
| Research And Development | $6,785,000 | $10,496,000 | $4,786,000 | $5,132,000 |
| Selling General And Administration | $5,187,000 | $6,089,000 | $3,533,000 | $2,418,000 |
| Other Gand A | $1,873,000 | $2,498,000 | $1,682,000 | $1,638,000 |
| Insurance And Claims | $670,000 | $874,000 | $608,000 | $75,000 |
| Salaries And Wages | $2,644,000 | $2,717,000 | $1,243,000 | $705,000 |
| Total Unusual Items | - | $0 | $-2,262,000 | $0 |
| Total Unusual Items Excluding Goodwill | - | $0 | $-2,262,000 | $0 |
| Preferred Stock Dividends | - | - | $1,324,000 | - |
| Other Special Charges | - | - | $2,262,000 | - |
| Rent And Landing Fees | - | - | - | $142,000 |
Fetched: 2026-06-25
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $11,876,000 | $2,918,000 | $13,162,000 | $-15,098,000 |
| Total Assets | $14,101,000 | $4,783,000 | $17,295,000 | $1,757,000 |
| Total Non Current Assets | $1,392,000 | $1,420,000 | $1,831,000 | $306,000 |
| Other Non Current Assets | $1,296,000 | $1,298,000 | $1,684,000 | $167,000 |
| Current Assets | $12,709,000 | $3,363,000 | $15,464,000 | $1,451,000 |
| Prepaid Assets | $788,000 | $773,000 | $688,000 | $63,000 |
| Cash Cash Equivalents And Short Term Investments | $11,921,000 | $2,590,000 | $14,776,000 | $1,312,000 |
| Cash And Cash Equivalents | $11,921,000 | $2,590,000 | $8,556,000 | $1,312,000 |
| Cash Equivalents | $11,835,000 | $2,162,000 | $8,189,000 | $0 |
| Cash Financial | $86,000 | $428,000 | $367,000 | $1,312,000 |
| Other Current Assets | - | - | $6,000 | $76,000 |
| Non Current Prepaid Assets | - | - | - | $167,738 |
| Receivables | - | - | - | $62,304 |
| Taxes Receivable | - | - | - | $15,903 |
| Debt | ||||
| Total Debt | $110,000 | $138,000 | $158,000 | $4,492,000 |
| Long Term Debt And Capital Lease Obligation | $79,000 | $110,000 | $138,000 | $0 |
| Current Debt And Capital Lease Obligation | $31,000 | $28,000 | $20,000 | $4,492,000 |
| Net Debt | - | - | - | $3,037,000 |
| Current Debt | - | - | - | $4,349,000 |
| Other Current Borrowings | - | - | - | $4,349,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,225,000 | $1,865,000 | $4,133,000 | $16,855,000 |
| Total Non Current Liabilities Net Minority Interest | $79,000 | $110,000 | $174,000 | $10,036,000 |
| Current Liabilities | $2,146,000 | $1,755,000 | $3,959,000 | $6,819,000 |
| Payables And Accrued Expenses | $1,315,000 | $1,671,000 | $3,547,000 | $2,327,000 |
| Payables | $583,000 | $1,219,000 | $3,048,000 | $603,000 |
| Accounts Payable | $583,000 | $1,219,000 | $3,048,000 | $603,000 |
| Other Non Current Liabilities | - | - | $36,000 | $36,000 |
| Equity | ||||
| Common Stock Equity | $11,876,000 | $2,918,000 | $13,162,000 | $-15,098,000 |
| Total Equity Gross Minority Interest | $11,876,000 | $2,918,000 | $13,162,000 | $-15,098,000 |
| Stockholders Equity | $11,876,000 | $2,918,000 | $13,162,000 | $-15,098,000 |
| Retained Earnings | $-78,389,000 | $-66,783,000 | $-50,515,000 | $-38,653,000 |
| Preferred Securities Outside Stock Equity | - | - | $0 | $10,000,000 |
| Preferred Stock Equity | - | - | - | $325 |
| Other | ||||
| Ordinary Shares Number | $2,524,475 | $604,914 | $548,375 | $523,975 |
| Share Issued | $2,524,475 | $604,914 | $548,375 | $523,975 |
| Tangible Book Value | $11,876,000 | $2,918,000 | $13,162,000 | $-15,098,000 |
| Invested Capital | $11,876,000 | $2,918,000 | $13,162,000 | $-10,749,000 |
| Working Capital | $10,563,000 | $1,608,000 | $11,505,000 | $-5,368,000 |
| Capital Lease Obligations | $110,000 | $138,000 | $158,000 | $143,000 |
| Total Capitalization | $11,876,000 | $2,918,000 | $13,162,000 | $-15,098,000 |
| Additional Paid In Capital | $90,265,000 | $69,701,000 | $63,676,000 | $23,555,000 |
| Capital Stock | $0 | $0 | $1,000 | $0 |
| Common Stock | $0 | $0 | $1,000 | $0 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $79,000 | $110,000 | $138,000 | $0 |
| Current Capital Lease Obligation | $31,000 | $28,000 | $20,000 | $143,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $800,000 | $56,000 | $392,000 | - |
| Current Accrued Expenses | $732,000 | $452,000 | $499,000 | $1,724,000 |
| Net PPE | $96,000 | $122,000 | $147,000 | $139,000 |
| Gross PPE | $96,000 | $122,000 | $147,000 | $139,000 |
| Other Properties | $96,000 | $122,000 | $147,000 | $139,000 |
| Other Short Term Investments | - | $0 | $6,220,000 | $0 |
| Duefrom Related Parties Current | - | - | - | $46,401 |
Fetched: 2026-06-25
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-9,233,000 | $-15,220,000 | $-7,205,000 | $-5,477,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-9,233,000 | $-15,220,000 | $-7,205,000 | $-5,477,000 |
| Cash Flow From Continuing Operating Activities | $-9,233,000 | $-15,220,000 | $-7,205,000 | $-5,477,000 |
| Operating Gains Losses | - | - | $2,262,000 | - |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $6,354,000 | $-6,023,000 | $0 |
| Cash Flow From Continuing Investing Activities | $0 | $6,354,000 | $-6,023,000 | $0 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $20,324,000 | $3,232,000 | $22,425,000 | $0 |
| Financing Cash Flow | $18,564,000 | $2,900,000 | $20,472,000 | $2,250,000 |
| Cash Flow From Continuing Financing Activities | $18,564,000 | $2,900,000 | $20,472,000 | $2,250,000 |
| Net Other Financing Charges | $-1,816,000 | $-653,000 | $-2,233,000 | - |
| Net Common Stock Issuance | $20,324,000 | $3,232,000 | $22,425,000 | $0 |
| Common Stock Issuance | $20,324,000 | $3,232,000 | $22,425,000 | $0 |
| Net Preferred Stock Issuance | - | - | - | - |
| Preferred Stock Issuance | - | - | - | - |
| Other | ||||
| End Cash Position | $11,921,000 | $2,590,000 | $8,556,000 | $1,312,000 |
| Beginning Cash Position | $2,590,000 | $8,556,000 | $1,312,000 | $4,539,000 |
| Changes In Cash | $9,331,000 | $-5,966,000 | $7,244,000 | $-3,227,000 |
| Proceeds From Stock Option Exercised | $56,000 | $321,000 | $50,000 | $0 |
| Net Investment Purchase And Sale | $0 | $6,354,000 | $-6,023,000 | $0 |
| Sale Of Investment | $0 | $9,410,000 | $9,030,000 | $0 |
| Purchase Of Investment | $0 | $-3,056,000 | $-15,053,000 | $0 |
| Change In Working Capital | $347,000 | $-1,967,000 | $-436,000 | $757,000 |
| Change In Payables And Accrued Expense | $360,000 | $-2,268,000 | $1,631,000 | $704,000 |
| Change In Payable | $360,000 | $-2,268,000 | $1,631,000 | $704,000 |
| Change In Account Payable | $360,000 | $-2,268,000 | $1,631,000 | $704,000 |
| Change In Prepaid Assets | $-13,000 | $301,000 | $-2,067,000 | $53,000 |
| Other Non Cash Items | $26,000 | $-58,000 | $109,000 | $179,000 |
| Stock Based Compensation | $2,000,000 | $3,073,000 | $1,398,000 | $1,169,000 |
| Net Income From Continuing Operations | $-11,606,000 | $-16,268,000 | $-10,538,000 | $-7,582,000 |
| Issuance Of Debt | - | $0 | $230,000 | $2,250,000 |
| Net Issuance Payments Of Debt | - | $0 | $230,000 | $2,250,000 |
| Net Short Term Debt Issuance | - | $0 | $230,000 | $2,250,000 |
| Short Term Debt Issuance | - | $0 | $230,000 | $2,250,000 |
| Change In Accrued Expense | - | - | $-197,000 | $0 |
| Change In Interest Payable | - | - | $-197,000 | $0 |
| Change In Other Current Liabilities | - | - | - | $-182,686 |
| Change In Other Current Assets | - | - | - | $52,529 |
Fetched: 2026-06-25